Clinical Trial: A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083193) titled 'A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis' on July 16.

Brief Summary: The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of AC-101 tablets in participants with moderate-to-severe ulcerative colitis.

The total study duration is up to 17 weeks, including 4-week screening, 12-week treatment period, and 1-week safety follow-up.

The study will enroll approximately 24 participants with moderate to severe active ulcerative colitis.

Study Start Date: Jan. 20

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis

Intervention: DRUG: AC-101

AC-101 tab...